Enterprise Value
-10.2M
Cash
46.48M
Avg Qtr Burn
-12.49M
Short % of Float
1.05%
Insider Ownership
7.27%
Institutional Own.
14.12%
Qtr Updated
06/30/23
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
FX-345 Details Sensorineural hearing loss, Ear disease | Failed Discontinued | |
FX-322 Details Ear disease, Sensorineural hearing loss | Failed Discontinued |